Acute neurolupus manifested by seizures is associated with high frequency of abnormal cerebral blood flow velocities

Cerebrovascular Diseases

Volumn 25, Issue 4, 2008, Pages 348-354

  Baizabal Carvallo, José Fidel ^a   Cantú Brito, Carlos ^a   García Ramos, Guillermo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cerebral blood flow; Cerebral hemodynamics; Epilepsy; Lupus; Microembolic signals; Small vessel diseases of the brain; Transcranial Doppler ultrasound

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; FLOW RATE; HUMAN; MALE; MICROEMBOLISM; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC LUPUS ERYTHEMATOSUS; PREVALENCE; PRIORITY JOURNAL; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROCIRCULATION; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PREVALENCE; SEIZURES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 42349115306     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118381     Document Type: Article

References (33)

1. Brey RL, Holliday SL, Saklad AR, et al: Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-1220.
2. Alarcón-Segovia D, Estañol B, García-Ramos G, Villa AR: Antiphospholipid antibodies and the antiphospholipid syndrome: clinical relevance in neuropsychiatric systemic lupus erythematosus. Ann NY Acad Sci 1997;823:279-288.
3. Jennekens FGI, Kater L: The central nervous system in systemic lupus erythematosus. 2. Pathogenic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002;41:619-630.
4. Afeltra A, Garzia P, Mitterhofer AP, et al: Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003;61:108-110.
5. Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-369.
6. Ellis SG, Verity MA: Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-221.
7. Hanly JG, Walsh NMG, Sangalang V: Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-741.
8. Rademacher J, Sohngen D, Specker C, Janda I, Sitzer M: Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus? Acta Neurol Scand 1999;99:356-361.
9. Russell D, Madden KP, Clark WM, et al: Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke 1991;22:253-258.
10. Markus H: Transcranial Doppler detection of circulating cerebral emboli: a review. Stroke 1993;24:1246-1250.
11. Siebler M, Nachtmann A, Sitzer M, et al: Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995;26:2184-2186.
12. Dahl A, Omdal R, Waterloo K, et al: Detection of cerebral embolic signals in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 2006;77:774-779.
13. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
14. Hochberg MC: Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
15. ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
17. Gladman D, Ginzler E, Goldsmith C, et al: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-368.
18. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
19. Ringelstein EB, Droste DW, Babikian VL, et al, International Consensus Group on Microembolus Detection: Consensus on microembolus detection by TCD. Stroke 1998;29:725-729.
20. Markus H, Bland JM, Rose G, Sitzer M, Siebler M: How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke 1996;27:1249-1252.
21. Markus HS, Ackerstaff R, Babikian V, et al: Intercenter agreement in reading Doppler embolic signals: a multicenter international study. Stroke 1997;28:1307-1310.
22. Gosling RG, Dunbar G, King DH, et al: The quantitative analysis of occlusive peripheral arterial disease by a noninvasive ultrasound technique. Angiology 1971;22:52-55.
23. Baumgartner RW, Mattle HP, Schroth G: Assessment of >50% and <50% intracranial stenosis by transcranial color-coded duplex sonography. Stroke 1999;30:87-92.
24. Rorick MB, Nichols FT, Adams RJ: Transcranial Doppler correlation with angiography detection of intracranial stenosis. Stroke 1994;25:1931-1934.
25. Ley-Pozo J, Ringelstein EB: Noninvasive detection of occlusive disease of the carotid siphon and middle cerebral artery. Ann Neurol 1990;28:640-647.
26. Devinsky O, Petito CK, Alonso DR: Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 1988;23:380-384.
27. Belmont HM, Abramson SB, Lie JT: Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996;39:9-22.
28. Graham JW, Jan W: MRI and the brain in systemic lupus erythematosus. Lupus 2003;12:891-896.
29. Tûnde C, Attila V, Béla F, Emese K, Gyula S, László C: Transcranial Doppler may reveal asymptomatic cerebral vasculopathy in systemic lupus erythematosus. Cerebrovasc Dis 1995;5:178-181.
30. Kumral E, Evyapan D, Keser G, et al: Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 2002;47:131-135.
31. Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK: Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project. Stroke 2000;31:1289-1293.
32. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schu PH, Hennekens CH: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997-1002.
33. Kron J, Hamper UM, Petri M: Prevalence of cerebral microemboli in systemic lupus erythematosus: transcranial Doppler. J Rheumatol 2001;28:10:2222-2225.